Sequencing of IL-10 Gene Promoter for -592 (A/C) and -1082 (A/G) Positions in Iraqi Children Patients with Type 1 Diabetes Mellitus

Abstract

We studied the relationship between DNA sequencing of interleukin-10 (IL-10) gene promoter for -1082 (A/G) and -592 (A/C) positions with the concentration of IL-10 in blood serum of Iraqi children with type 1 diabetes mellitus (T1D). Fifty blood serum samples collected from children with age ranged between 7-12 years. Thirty-five blood samples collected from patient children with T1D, and compared with 15 healthy children age matched as control sample. The results revealed decreasing in anti-inflammatory IL-10 concentration in T1D patient’s blood serum (0.068 Pg/ml) as compared with the control sample (0.111 Pg/ml). No significant differences were found in interleukin concentration between the studied samples when they analyzed with the Mann-Whitney U test. The DNA sequences of the IL-10 gene promoter in 12 selected samples were recorded many gene mutations with addition, deletion and substitution types in all of the studied samples for the both -592 (A/C) and -1082 (A/G) positions. The 12 sequenced PCR products were submitted in the NCBI gene bank. The accessions numbers of these submitted sequences started from KX138250 to KX138261. In conclusions, low or absent concentration levels of IL-10 was found in T1D patient blood serums. Also, many gene mutations were detected in IL-10 gene promoter for the studied sequences of T1D patients as compared with the same gene promoter which published in NCBI. These mutations maybe related with no or low concentration of IL-10 in T1D patient serums.